welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Therapeutic Approaches for Patients with Coexisting Familial Adenomatous Polyposis and Colorectal Cancer
source: Japanese Journal of Clinical Oncology
year: 2016
authors: Yasuhiro Inoue, Hideyuki Ishida, Hideki Ueno, Hirotoshi Kobayashi, Tatsuro Yamaguchi, Tsuyoshi Konishi, Naohiro Tomita, Nagahide Matsubara, Fumio Ishida, Takao Hinoi, Yukihide Kanemitsu, Toshiaki Watanabe, Kenichi Sugihara
summary/abstract:Colorectal cancer is a major cause of death in patients with familial adenomatous polyposis. Despite evidence for prophylactic colectomy, there is no ideal therapy for patients with coexisting familial adenomatous polyposis and colorectal cancer. We evaluated the correlation between surgery for familial adenomatous polyposis and multimodal treatment for colorectal cancer, and clarified prognosis of Japanese patients with familial adenomatous polyposis and colorectal cancer.
organization: Mie University Graduate School of Medicine, Saitama Medical University, Tokyo Medical and Dental University, Japanese Foundation for Cancer ResearchDOI: 10.1093/jjco/hyw086
read more full text source
expertly curated content related to this topic
- Desmoid Tumors: Clinical Features and Treatment Options for Advanced DiseaseDesmoid tumors describe a rare monoclona...
- Surgical Management of the Duodenal Manifestations of Familial Adenomatous PolyposisBACKGROUND: Duodenal adenomas develop i...
- A 17-Year-Old Boy with Familial Adenomatous Polyposis and Unexpected Endoscopy FindingsA 17-year-old boy with familial adenomat...
- Targeted Therapy for Hereditary Cancer Syndromes: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Fam...Cancer genetics has rapidly evolved in t...
- Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)To test whether celecoxib can be used to...
- Cancer Prevention Pharmaceuticals, Inc. and Tillotts Pharma AG Sign Licensing Agreement for CPP-1X/sulindac in Europ...Cancer Prevention Pharmaceuticals, Inc. ...
- Risk-Reducing Surgery in FAP: Role for Surgeons Beyond the IncisionBACKGROUND : Although primary therapy in...